Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 3 open-market purchases and 0 sales; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Holders of 5% or more of LPCN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lipocine Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Squadron Capital Management LLC | 13G/A | 9.80%810.0K shares | +3.60 ppfrom 6.20% | Dec 23, 20254 filings | Aug 14, 2026 | SEC |
| Ikarian Capital, LLC | 13G | 6.30%508.6K shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Lipocine Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20261:01 PM ET | Squadron Capital Management LLCand 3 others | 13G/A | 9.80%810.0K shares | +3.60 ppfrom 6.20% | Jun 30, 2026 | SEC |
| May 15, 20265:00 PM ET | Ikarian Capital, LLCand 1 other | 13G | 6.30%508.6K shares | New | Mar 31, 2026 | SEC |
| May 15, 202611:55 AM ET | Squadron Capital Management LLCand 3 others | 13G/A | 6.20%450.0K shares | −3.30 ppfrom 9.50% | Mar 31, 2026 | SEC |
| Feb 17, 202611:49 AM ET | Squadron Capital Management LLCand 3 others | 13G/A | 9.50%530.0K shares | +0.50 ppfrom 9.00% | Dec 31, 2025 | SEC |
| Dec 23, 20253:49 PM ET | Squadron Capital Management LLCand 3 others | 13G | 9.00%500.0K shares | New | Dec 18, 2025 | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Jan 5, 2021 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lipocine Inc. shares.
No Form 144 notices for Lipocine Inc. are on file.